Ekos Corp.: FDA filings under this applicant name
FDA lists 25 510(k) clearances under 2 spellings of the applicant name “Ekos Corp.” (first 2003, latest 2020), across 4 product codes in 2 review panels. Median 510(k) review time under this name: 28 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 1 | 158 |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Ekos Corp. took a median 158 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 111 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| QEY | Mechanical Thrombolysis Catheter | 19 | 19 |
| NUI | Ultrasound, Infusion, System | 4 | 4 |
| DRA | Catheter, Steerable | 1 | 1 |
| KRA | Catheter, Continuous Flush | 1 | 1 |
Review panels
- Cardiovascular (21)
- Neurology (4)
Most recent Ekos Corp. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K200648 | EKOS PE Endovascular Device with Control System 4.0 (CS4.0) | QEY | 2020-08-17 | 158 |
| K111705 | EKOSONIC ENDOVASCULAR SYSTEM | QEY | 2011-08-03 | 47 |
| K081467 | EKOSONIC ENDOVASCULAR SYSTEM WITH RAPID PULSE MODULATION | QEY | 2008-06-26 | 30 |
| K080392 | EndoWave Infusion System | QEY | 2008-04-30 | 77 |
| K073166 | ENDOWAVE INFUSION SYSTEM | KRA | 2008-04-22 | 165 |
| K072507 | ENDOWAVE INFUSION SYSTEM | QEY | 2007-10-04 | 28 |
| K071933 | ENDOWAVE INFUSION SYSTEM | QEY | 2007-08-10 | 28 |
| K063620 | EKOS MICRO-INFUSION SYSTEM | QEY | 2007-08-06 | 244 |
| K062508 | NEUROWAVE MICRO-INFUSION SYSTEM | NUI | 2006-12-05 | 99 |
| K062507 | MICRO-INFUSION SYSTEM | QEY | 2006-11-22 | 86 |
15 earlier clearances. See the full list in Caduvo.
Recalls
14 product recalls in 14 recall events; 0 initiated in the last five years. Most recent: 2016-08-22.
1 product recall in 1 recall event filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 1 initiated in the last five years. Most often: Boston Scientific Corporation (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Ekos Corp. (23)
- Ekos Corporation (2)
Frequently asked questions
How many FDA 510(k) clearances are listed under Ekos Corp.?
FDA lists 25 510(k) clearances under 2 spellings of the applicant name “Ekos Corp.” (first 2003, latest 2020), across 4 product codes in 2 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Ekos Corp.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Ekos Corp. is 28 days.
Which FDA product codes appear under Ekos Corp.?
The most frequent FDA product codes under this applicant name are QEY (Mechanical Thrombolysis Catheter, 19); NUI (Ultrasound, Infusion, System, 4); DRA (Catheter, Steerable, 1).
Next steps
- See all 25 Ekos Corp. clearances with predicates and recalls
- Run predicate analysis for product code QEY, Ekos Corp.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.